1. Home
  2. MGLD vs PDSB Comparison

MGLD vs PDSB Comparison

Compare MGLD & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Marygold Companies Inc.

MGLD

The Marygold Companies Inc.

BUY

Current Price

$0.99

Market Cap

44.8M

Sector

Finance

ML Signal

BUY

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$0.83

Market Cap

42.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGLD
PDSB
Founded
1996
2005
Country
United States
United States
Employees
N/A
10
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.8M
42.4M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
MGLD
PDSB
Price
$0.99
$0.83
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.00
AVG Volume (30 Days)
9.3K
44.6M
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.16
EPS
N/A
N/A
Revenue
$34,876,734.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.84
$0.20
52 Week High
$1.38
$1.55

Technical Indicators

Market Signals
Indicator
MGLD
PDSB
Relative Strength Index (RSI) 39.89 78.28
Support Level $0.89 $0.81
Resistance Level $1.07 $1.11
Average True Range (ATR) 0.05 0.12
MACD -0.00 0.08
Stochastic Oscillator 18.00 78.70

Price Performance

Historical Comparison
MGLD
PDSB

About MGLD The Marygold Companies Inc.

The Marygold Companies Inc is an international holding company focused on acquiring and growing profitable businesses. Its main segments include U.S. Fund Management through USCF Investments, Food Products via Gourmet Foods and Printstock Products in New Zealand, Beauty Products under the Original Sprout brand, and formerly Security Systems through Brigadier, sold in 2025. The majority of revenue comes from fund management. The company operates in the USA, New Zealand, the United Kingdom, and Canada, with the majority of revenue generated from the USA. Its business approach focuses on strengthening financial services, expanding fintech, and managing a diverse portfolio for growth.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.

Share on Social Networks: